Based in BOSTON, MA, INTERNATIONAL MYELOMA SOCIETY operates as a Public Charity. The organization reported $11.8M in revenue, $9.7M in expenses, $10.8M in total assets for fiscal year 2024. Imperigo tracks 1 reported grant relationships connected to this organization totaling approximately $100K.
THE INTERNATIONAL MYELOMA SOCIETY (IMS) IS A PROFESSIONAL, SCIENTIFIC,AND MEDICAL SOCIETY ESTABLISHED TO BRING TOGETHER CLINICAL ANDEXPERIMENTAL SCIENTISTS INVOLVED IN THE STUDY OF MYELOMA. THE PURPOSEOF THIS SOCIETY IS TO PROMOTE RESEARCH, EDUCATION, CLINICAL STUDIES (INCLUDING DIAGNOSIS AND TREATMENT), WORKSHOPS, CONFERENCES AND SYMPOSIA ON ALL ASPECTS OF MULTIPLE MYELOMA AND RELATED DISORDERS WORLDWIDE.
How International Myeloma Society divides every $100 it spends, from its own Form 990 filings, averaged across 5 years.
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Showing up to 5 of 1 total records — full history available with membership.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $11.8M | $9.7M | $10.8M |
| 2023 | $11.4M | $9.4M | $8.8M |
| 2022 | $3.6M | $2.6M | $8.3M |
| 2020 | $2.3M | $115K | $4.7M |
| 2019 | $4.3M | $3.4M | $2.6M |
Between 2019 and 2024, reported annual revenue grew from $4.3M to $11.8M (+177%), with total assets most recently reported at $10.8M.
Interactive year-over-year charts and full filing details available with membership.
